BCL2 and pancreatic neoplasm: Our study demonstrated that the new compound 2 significantly induced apoptosis in human pancreatic tumor cells (PATU8988T), characterized by the morphologies abnormity, the reduction of cell number, the upregulation of proportion of apoptotic cells, and decrease in the ratio of Bcl-2 to Bax.